InFLAMES Flagship
Contact Details
Persons
1 of 3
Publications
19 of 171
- Benefits of Mandated Registries for Generating Real-World Outcome DataBioactive glasses promote rapid pre-osteoblastic cell migration in contrast to hydroxyapatite, while carbonated apatite shows migration inhibiting properties (2023)
- Bexmarilimab Activates Human Tumor-Associated Macrophages to Support Adaptive Immune Responses in Interferon-Poor Immune MicroenvironmentsBioaffinity Recognition of Extracellular Vesicle Glycosylations (2024)
- Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors : The phase I/II first-in-human MATINS trialBiodistribution, Safety Profile, and Radiation Dosimetry of [18F]SYN2, a PET Cardiac Perfusion Tracer, in Healthy Subjects (2023)
- Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trial (2025)
- Bias in O-Information Estimation (2024)
- Bilayer Fiber‐Reinforced Composite‐Hydrogel Scaffolds With Bioactive Glass for Bone Tissue Regeneration (2026)
- 2023
- (2024)
- (2025)
- (2025)
UTU Research Portal